Trump and Future Cancer Cures

President Trump sure has ironic timing. On Sunday Gilead Sciences announced a $21 billion offer to buy Immunomedics, which recently launched a breakthrough therapy for hard-to-treat metastatic breast cancer. Hours later Mr. Trump signed an executive order that could make other life-saving therapies less likely.

Mr. Trump has been threatening drug makers for months with government price controls. He thinks targeting Big Pharma is a good election issue, though he’ll never get to the left of Speaker Nancy Pelosi and Joe Biden.

Leave a Reply

Back to top